Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Deciphera Pharmaceuticals (DCPH) stocks in Canada
Learn how to easily invest in Deciphera Pharmaceuticals stocks.
Deciphera Pharmaceuticals is a drug manufacturers-specialty & generic business based in the US. Deciphera Pharmaceuticals stocks (DCPH.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $35.1 – a decrease of 3.61% over the previous week. Deciphera Pharmaceuticals employs 350 staff and has a trailing 12-month revenue of around $91.4 million.
How to buy shares in Deciphera Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – DCPH – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Is it a good time to buy Deciphera Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
What's in this guide?
- Can I buy shares in Deciphera Pharmaceuticals?
- Has coronavirus impacted Deciphera Pharmaceuticals shares?
- Deciphera Pharmaceuticals shares summary
- Compare share dealing platforms
- Is Deciphera Pharmaceuticals stock a buy or sell?
- Deciphera Pharmaceuticals performance over time
- Deciphera Pharmaceuticals's financials
- How volatile are Deciphera Pharmaceuticals shares?
- Does Deciphera Pharmaceuticals pay a dividend?
- Other common questions
How has Coronavirus impacted Deciphera Pharmaceuticals's stock price?
Since the stock market crash in March caused by coronavirus, Deciphera Pharmaceuticals's stock price has had significant negative movement.
Its last market close was $8.27, which is 84.99% down on its pre-crash value of $55.1 and 300.24% down on the lowest point reached during the March crash when the stocks fell as low as $33.1.
If you had bought $1,000 worth of Deciphera Pharmaceuticals stocks at the start of February 2020, those stocks would have been worth $558.97 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $126.61.
Deciphera Pharmaceuticals stock price (NASDAQ:DCPH)Use our graph to track the performance of DCPH stocks over time.
Deciphera Pharmaceuticals shares at a glance
|Latest market close||$8.27|
|52-week range||$7.63 - $52.43|
|50-day moving average||$9.66|
|200-day moving average||$28.66|
|Wall St. target price||$12.22|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-4.75|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Deciphera Pharmaceuticals price performance over time
|1 week (2022-01-12)||-3.61%|
|1 month (2021-12-16)||-9.42%|
|3 months (2021-10-19)||-75.65%|
|6 months (2021-07-19)||-75.19%|
|1 year (2021-01-19)||-83.28%|
|2 years (2020-01-17)||-88.08%|
|3 years (2019-01-18)||26.75|
|5 years (2017-01-15)||N/A|
Deciphera Pharmaceuticals financials
|Revenue TTM||$91.4 million|
|Gross profit TTM||$-157,108,000|
|Return on assets TTM||-30.04%|
|Return on equity TTM||-57.78%|
|Market capitalisation||$483.6 million|
TTM: trailing 12 months
Deciphera Pharmaceuticals share dividends
We're not expecting Deciphera Pharmaceuticals to pay a dividend over the next 12 months.
Deciphera Pharmaceuticals share price volatility
Over the last 12 months, Deciphera Pharmaceuticals's shares have ranged in value from as little as $7.63 up to $52.43. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Deciphera Pharmaceuticals's is 1.506. This would suggest that Deciphera Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Deciphera Pharmaceuticals overview
Deciphera Pharmaceuticals, Inc. , a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing immunokinase inhibitors comprising vimseltinib (DCC-3014) that is in Phase 1b/2 clinical trial for the treatment of tenosynovial giant cell tumors; and Rebastinib, which is in Phase 1b/2 clinical trial to treat metastatic solid tumors, as well as to investigate in combination with chemotherapy for the treatment of multiple solid tumors. In addition, it is developing DCC-3116 to treat RAS/RAF mutant cancers that is in the preclinical-stage. The company serves in the United States and Europe. Deciphera Pharmaceuticals, Inc.
Stocks similar to Deciphera Pharmaceuticals
Frequently asked questions
Deciphera Pharmaceuticals in the news
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Deciphera Pharmaceuticals (DCPH) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.